Related Experiment Videos
Apoptotic pathways and therapy resistance in human malignancies
Kristina Viktorsson1, Rolf Lewensohn, Boris Zhivotovsky
1Unit of Medical Radiobiology, Department of Oncology/Pathology, Cancer Center Karolinska, Karolinska Institute, S-171 76 Stockholm, Sweden.
Advances in Cancer Research
|August 13, 2005
Summary
Apoptosis and necrosis are distinct cell death types crucial for homeostasis. Understanding tumor apoptosis pathways is key to overcoming therapy resistance and developing novel cancer treatments.
Area of Science:
- Cellular Biology
- Oncology
- Pharmacology
Background:
- Apoptosis and necrosis are distinct cell death mechanisms vital for homeostasis.
- Tumor response to therapy is linked to their propensity for apoptosis or necrosis.
- Therapy resistance in tumors may stem from defects in apoptotic pathways.
Purpose of the Study:
- To discuss apoptotic pathways and their role in cancer therapy resistance.
- To explore the potential of targeting apoptosis for improved cancer treatment.
- To highlight the promise of pro-apoptotic drugs in combination therapies.
Main Methods:
- Review of existing literature on apoptosis, necrosis, and cancer therapy.
- Analysis of the mechanisms underlying tumor resistance to conventional treatments.
- Discussion of molecular pathways involved in programmed cell death.
Main Results:
- Tumor response varies, with hematologic cancers often showing rapid apoptosis induction.
- Solid tumors may exhibit slower responses involving apoptosis, necrosis, and mitotic catastrophe.
- Defects in apoptotic pathways are implicated in tumor resistance to various therapies.
Conclusions:
- Targeting apoptotic pathways offers a promising strategy for overcoming cancer therapy resistance.
- Development of pro-apoptotic drugs could enhance existing cancer treatment regimens.
- Future cancer therapy will likely involve combination approaches using conventional and targeted pro-apoptotic agents.